News & Updates

Genetically elevated FT4 levels tied to higher age-related macular degeneration risk
Genetically elevated FT4 levels tied to higher age-related macular degeneration risk
19 Feb 2022
Stroke risk elevated first 3 days post–COVID-19 diagnosis
Stroke risk elevated first 3 days post–COVID-19 diagnosis
18 Feb 2022 byRoshini Claire Anthony

Older patients with COVID-19 may have an increased risk of being hospitalized for acute ischaemic stroke (AIS), particularly in the first 3 days following their COVID-19 diagnosis, according to a study presented at ISC 2022.

Stroke risk elevated first 3 days post–COVID-19 diagnosis
18 Feb 2022
Ixazomib dexamethasone a new treatment in the arsenal against RRMM
Ixazomib dexamethasone a new treatment in the arsenal against RRMM
18 Feb 2022

In heavily pretreated, lenalidomide-refractory patients with relapsed-refractory multiple myeloma (RRMM) and prior exposure to proteasome inhibitors, ixazomib dexamethasone may be an effective and tolerable treatment approach, leading to comparable health-related quality of life outcomes as pomalidomide-dexamethasone, a recent study has found.

Ixazomib dexamethasone a new treatment in the arsenal against RRMM
18 Feb 2022
Being physically active helps prevent NAFLD
Being physically active helps prevent NAFLD
18 Feb 2022 byStephen Padilla

Physical activity (PA) is associated with a lower prevalence of nonalcoholic fatty liver disease (NAFLD), with greater benefits for higher PA intensities, reveals a study. Better metabolic health, particularly lower waist circumference and insulin resistance, mediates this association.

Being physically active helps prevent NAFLD
18 Feb 2022